Akèy › Maladi selil fòs › Pennsylvania › Philadelphia
Etid klinik pou Maladi selil fòs nan Philadelphia, PA
15 etid pou Maladi selil fòs ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Ap rekriteFaz 3
- Thomas Jefferson University Me, Philadelphia
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Ap rekriteFaz 3
- Children's Hosptl Philadelphia, Philadelphia
- St Christopher Hosp for Child, Philadelphia
- Nemours/AI duPont Hosp-Chld, Wilmington · 25 mi lwen
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Ap rekriteFaz 1/2Volontè an sante akeyi
- Childrens Hospital Of Philadelphia, Philadelphia
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Ap rekriteFaz 1/2Volontè an sante akeyi
- Local Institution - 0029, Philadelphia
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Ap rekriteEtid obsèvasyon
- Children's Hospital of Philadelphia, Philadelphia
- Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
- St. Christopher's Hospital for Children, Philadelphia
- ak 1 plis
Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
Ap rekrite
- Nemours Children's Hospital, Delaware, Wilmington · 25 mi lwen
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- Children's Hospital of Philadelphia (MRD-HCT), Philadelphia
- Nemours Children's Hospital, Delaware (MRD-HCT), Wilmington · 25 mi lwen
Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Ap rekriteFaz 1/2
- Children's Hospital of Philadelphia, Philadelphia
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Ap rekriteFaz 1/2
- Nemours Children's Health, Wilmington · 25 mi lwen
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Ap rekriteFaz 4
- Children's Hospital of Philadelphia, Philadelphia
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
Ap rekrite
- Children's Hospital of Philadelphia, Philadelphia
- Nemours Children's Health, Wilmington · 25 mi lwen
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
Ap rekriteFaz 2
- Children's Hospital of Philadelphia, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease
Ap rekrite
- University of Pennsylvania, Philadelphia
A Long-term Follow-up Study in Patients Who Received BEAM-101
Ap rekriteEtid obsèvasyon
- Children's Hospital of Philadelphia, Philadelphia
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- University of Pennsylvania, Philadelphia
Etid Maladi selil fòs nan lòt vil
- Atlanta, GA22 etid
- Washington, DC20 etid
- Chicago, IL18 etid
- Memphis, TN18 etid
- Birmingham, AL14 etid
- New York City, NY13 etid
- St. Louis, MO12 etid
- Boston, MA10 etid
- Durham, NC10 etid
- Houston, TX10 etid
- Cincinnati, OH10 etid
- Greenville, NC9 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè pwostat44 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.